5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase.

Insulin regulates the rate of expression of many hepatic genes, including PEPCK, glucose-6-phosphatase (G6Pase), and glucose-6-phosphate dehydrogenase (G6PDHase). The expression of these genes is also abnormally regulated in type 2 diabetes. We demonstrate here that treatment of hepatoma cells with 5-aminoimidazole-4-carboxamide riboside (AICAR), an agent that activates AMP-activated protein kinase (AMPK), mimics the ability of insulin to repress PEPCK gene transcription. It also partially represses G6Pase gene transcription and yet has no effect on the expression of G6PDHase or the constitutively expressed genes cyclophilin or beta-actin. Several lines of evidence suggest that the insulin-mimetic effects of AICAR are mediated by activation of AMPK. Also, insulin does not activate AMPK in H4IIE cells, suggesting that this protein kinase does not link the insulin receptor to the PEPCK and G6Pase gene promoters. Instead, AMPK and insulin may lie on distinct pathways that converge at a point upstream of these 2 gene promoters. Investigation of the pathway by which AMPK acts may therefore give insight into the mechanism of action of insulin. Our results also suggest that activation of AMPK would inhibit hepatic gluconeogenesis in an insulin-independent manner and thus help to reverse the hyperglycemia associated with type 2 diabetes.

[1]  C. Newgard,et al.  The Repression of Hormone-activated PEPCK Gene Expression by Glucose Is Insulin-independent but Requires Glucose Metabolism* , 1998, The Journal of Biological Chemistry.

[2]  L. Hue,et al.  Apoptosis induced by growth factor withdrawal in fibroblasts overproducing fructose 2,6‐bisphosphate , 1999, FEBS letters.

[3]  D. Granner,et al.  Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin , 1983, Nature.

[4]  N. Barzilai,et al.  Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. , 1993, The Journal of biological chemistry.

[5]  D. Carling,et al.  AMP-activated Protein Kinase Inhibits the Glucose-activated Expression of Fatty Acid Synthase Gene in Rat Hepatocytes* , 1998, The Journal of Biological Chemistry.

[6]  G. Schütz,et al.  Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Sutherland,et al.  Oxidative and Chemical Stress Mimic Insulin by Selectively Inhibiting the Expression of Phosphoenolpyruvate Carboxykinase in Hepatoma Cells , 1997, Diabetes.

[8]  M. Magnuson,et al.  Location and characterization of two widely separated glucocorticoid response elements in the phosphoenolpyruvate carboxykinase gene , 1988, Molecular and cellular biology.

[9]  J. Foster,et al.  Glucose-6-Phosphatase Structure, Regulation, and Function: An Update 1 , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  D. Hardie,et al.  AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.

[11]  J. Flier,et al.  Insulin Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression Does Not Require Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway (*) , 1996, The Journal of Biological Chemistry.

[12]  R. O’Brien,et al.  Central Role for Phosphatidylinositide 3-Kinase in the Repression of Glucose-6-phosphatase Gene Transcription by Insulin* , 1998, The Journal of Biological Chemistry.

[13]  R. O’Brien,et al.  Signal transduction convergence: phorbol esters and insulin inhibit phosphoenolpyruvate carboxykinase gene transcription through the same 10-base-pair sequence. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Hardie,et al.  AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. , 1999, The Biochemical journal.

[15]  R. O’Brien,et al.  Regulation of phosphoenolpyruvate carboxykinase gene expression by insulin. Use of the stable transfection approach to locate an insulin responsive sequence. , 1990, Molecular endocrinology.

[16]  B. Kemp,et al.  Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. , 1992, The Journal of biological chemistry.

[17]  G. Shulman,et al.  Effect of AMPK activation on muscle glucose metabolism in conscious rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[18]  A. Lange,et al.  Regulation of Rat Liver Glucose-6-Phosphatase Gene Expression in Different Nutritional and Hormonal States: Gene Structure and 5′-Flanking Sequence , 1996, Diabetes.

[19]  B Lin,et al.  Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids. , 1998, DNA and cell biology.

[20]  D. Hardie,et al.  AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. , 1998, The Biochemical journal.

[21]  R. Printz,et al.  Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. , 1995, Biochimica et biophysica acta.

[22]  D. Hardie,et al.  Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. , 1996, The American journal of physiology.

[23]  J. Proietto,et al.  Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene. , 1995, Molecular endocrinology.

[24]  R. O’Brien,et al.  Integration of multiple signals through a complex hormone response unit in the phosphoenolpyruvate carboxykinase gene promoter. , 1994, Molecular endocrinology.

[25]  W. Roesler,et al.  Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism. , 1999, Biochimica et biophysica acta.

[26]  R. O’Brien,et al.  New connections in the regulation of PEPCK gene expression by insulin. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[27]  D. Powell,et al.  Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor-binding protein-1 through proximal promoter elements. , 1994, The Journal of biological chemistry.

[28]  S. Hawley,et al.  Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[29]  M. Carlson,et al.  The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.

[30]  A. Lange,et al.  Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. , 1994, Biochemical and biophysical research communications.

[31]  P. Seglen,et al.  Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. , 1998, The Journal of biological chemistry.

[32]  C. Newgard,et al.  Perturbation of Fuel Homeostasis Caused by Overexpression of the Glucose-6-phosphatase Catalytic Subunit in Liver of Normal Rats* , 1998, The Journal of Biological Chemistry.

[33]  G. Lopaschuk,et al.  High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5′-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase (*) , 1995, The Journal of Biological Chemistry.

[34]  D. Carling,et al.  Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. , 1989, European journal of biochemistry.

[35]  R. O’Brien,et al.  PEPCK Gene as Model of Inhibitory Effects of Insulin on Gene Transcription , 1990, Diabetes Care.

[36]  R. O’Brien,et al.  Regulation of gene expression by insulin. , 1996, The Biochemical journal.

[37]  J. Girard,et al.  Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. , 1998, Diabetes.

[38]  C. Caldarera,et al.  Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase. , 1998, Biochemical and biophysical research communications.

[39]  G. Velasco,et al.  Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. , 1997, Archives of biochemistry and biophysics.

[40]  J. Friedman,et al.  Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription and Hyperglycemia Are Regulated by Glucocorticoids in Genetically Obesedb/db Transgenic Mice* , 1997, The Journal of Biological Chemistry.

[41]  D. Hardie,et al.  The α1 and α2 isoforms of the AMP‐activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro , 1996 .

[42]  Tatsuya Hayashi,et al.  Evidence for 5′AMP-Activated Protein Kinase Mediation of the Effect of Muscle Contraction on Glucose Transport , 1998, Diabetes.

[43]  J. Wang,et al.  Hepatic nuclear factor 3 is an accessory factor required for the stimulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. , 1996, Molecular endocrinology.

[44]  G. Shulman,et al.  Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. , 1999, The American journal of physiology.

[45]  T. Fujiwara,et al.  Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL KsJ-db db mice , 1995 .

[46]  N. Barzilai,et al.  Glucose Regulates in Vivo Glucose-6-phosphatase Gene Expression in the Liver of Diabetic Rats (*) , 1996, The Journal of Biological Chemistry.

[47]  S. Stapleton,et al.  Insulin Regulation of Glucose-6-phosphate Dehydrogenase Gene Expression Is Rapamycin-sensitive and Requires Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.

[48]  R. Coleman,et al.  AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. , 1999, The Biochemical journal.

[49]  J. Castaño.  Regulation of gene expression by insulin. , 1991, Advances in enzyme regulation.

[50]  R. Hanson,et al.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.

[51]  L. Goodyear,et al.  5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. , 1999, Diabetes.

[52]  D. Schmoll,et al.  Cloning and sequencing of the 5′ region of the human glucose‐6‐phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells , 1996, FEBS letters.

[53]  D. Hardie,et al.  Role of the AMP-activated protein kinase in the cellular stress response , 1994, Current Biology.

[54]  I. Leclerc,et al.  The 5′‐AMP‐activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex , 1998, FEBS letters.

[55]  G. Lopaschuk,et al.  Insulin inhibition of 5' adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. , 1997, Metabolism: clinical and experimental.

[56]  R. O’Brien,et al.  Phosphatidylinositol 3-Kinase, but Not p70/p85 Ribosomal S6 Protein Kinase, Is Required for the Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Gene Expression by Insulin , 1995, The Journal of Biological Chemistry.

[57]  D. Hardie,et al.  AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.

[58]  S. Hawley,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[59]  H. Ronne,et al.  Yeast MIG1 repressor is related to the mammalian early growth response and Wilms' tumour finger proteins. , 1990, The EMBO journal.

[60]  A. Edelman,et al.  5′-AMP Activates the AMP-activated Protein Kinase Cascade, and Ca2+/Calmodulin Activates the Calmodulin-dependent Protein Kinase I Cascade, via Three Independent Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[61]  M. Vincent,et al.  Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP‐activated protein kinase , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.